BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 15949643)

  • 1. Cardiac actions of central but not peripheral urotensin II are prevented by beta-adrenoceptor blockade.
    Hood SG; Watson AM; May CN
    Peptides; 2005 Jul; 26(7):1248-56. PubMed ID: 15949643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic, pulmonary and coronary haemodynamic actions of the novel dopamine receptor agonist in awake pigs at rest and during treadmill exercise Z1046.
    Duncker DJ; Haitsma DB; van der Geest IE; Stubenitsky R; van Meegen JR; Man in't Veld AJ; Verdouw PD
    Br J Pharmacol; 1997 Mar; 120(6):1101-13. PubMed ID: 9134223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct cardiac and vascular actions of adrenomedullin in conscious sheep.
    Parkes DG; May CN
    Br J Pharmacol; 1997 Mar; 120(6):1179-85. PubMed ID: 9134233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of central urotensin II on heart rate, blood pressure and brain Fos immunoreactivity in conscious rats.
    Watson AM; McKinley MJ; May CN
    Neuroscience; 2008 Jul; 155(1):241-9. PubMed ID: 18597948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urotensin II acts centrally to increase epinephrine and ACTH release and cause potent inotropic and chronotropic actions.
    Watson AM; Lambert GW; Smith KJ; May CN
    Hypertension; 2003 Sep; 42(3):373-9. PubMed ID: 12885791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urotensin II, a novel peptide in central and peripheral cardiovascular control.
    Watson AM; May CN
    Peptides; 2004 Oct; 25(10):1759-66. PubMed ID: 15476943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular effects of centrally acting orexin A in haemorrhage-shocked rats.
    Jochem J; Zwirska-Korczala K; Zabielski R; Kato I; Kuwahara A
    J Physiol Pharmacol; 2006 Nov; 57 Suppl 11():115-24. PubMed ID: 17244943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urocortin 1 exhibits potent inhibition of cardiac sympathetic nerve activity in conscious sheep.
    Charles CJ; Jardine DL; Nicholls MG; Rademaker MT; Richards AM
    J Hypertens; 2008 Jan; 26(1):53-60. PubMed ID: 18090540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time-course effects of centrally administered native urotensin-II on motor and cardioventilatory activity in trout.
    Lancien F; Leprince J; Mimassi N; Mabin D; Vaudry H; Le Mével JC
    Ann N Y Acad Sci; 2005 Apr; 1040():371-4. PubMed ID: 15891065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular effects of the novel Ca2+-sensitiser EMD 57033 in pigs at rest and during treadmill exercise.
    Stubenitsky R; van der Weerd RW; Haitsma DB; Verdouw PD; Duncker DJ
    Br J Pharmacol; 1997 Dec; 122(7):1257-70. PubMed ID: 9421271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct actions of urotensin II on the heart: implications for cardiac fibrosis and hypertrophy.
    Tzanidis A; Hannan RD; Thomas WG; Onan D; Autelitano DJ; See F; Kelly DJ; Gilbert RE; Krum H
    Circ Res; 2003 Aug; 93(3):246-53. PubMed ID: 12842917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central effects of native urotensin II on motor activity, ventilatory movements, and heart rate in the trout Oncorhynchus mykiss.
    Lancien F; Leprince J; Mimassi N; Mabin D; Vaudry H; Le Mével JC
    Brain Res; 2004 Oct; 1023(2):167-74. PubMed ID: 15374742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The beta-adrenoceptor subtype(s) mediating adrenaline- and dobutamine-induced blood pressure and heart rate changes in healthy volunteers.
    Daul A; Hermes U; Schäfers RF; Wenzel R; von Birgelen C; Brodde OE
    Int J Clin Pharmacol Ther; 1995 Mar; 33(3):140-8. PubMed ID: 7599912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular actions of trout urotensin II in the conscious trout, Oncorhynchus mykiss.
    Le Mevel JC; Olson KR; Conklin D; Waugh D; Smith DD; Vaudry H; Conlon JM
    Am J Physiol; 1996 Nov; 271(5 Pt 2):R1335-43. PubMed ID: 8945972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of force--frequency relation during AV-block, sinus node block and beta-adrenoceptor block in conscious animals.
    De Pauw M; Vilaine JP; Heyndrickx GR
    Basic Res Cardiol; 2004 Sep; 99(5):360-71. PubMed ID: 15338245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of urocortin II administration on the coronary circulation and cardiac function in the anaesthetized pig is nitric-oxide-dependent.
    Grossini E; Molinari C; Mary DA; Marino P; Vacca G
    Eur J Pharmacol; 2008 Jan; 578(2-3):242-8. PubMed ID: 17936748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of peripherally administered urotensin II and arginine vasotocin on the QT interval of the electrocardiogram in trout.
    Vanegas G; Lancien F; Leprince J; Vaudry H; Le Mével JC
    Comp Biochem Physiol C Toxicol Pharmacol; 2016; 183-184():53-60. PubMed ID: 26902806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of centrally administered dexmedetomidine on cardiovascular and sympathetic function in conscious rats.
    Shirasaka T; Qiu DL; Kannan H; Takasaki M
    Anesth Analg; 2007 Dec; 105(6):1722-8, table of contents. PubMed ID: 18042874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimated central blood volume in cirrhosis: relationship to sympathetic nervous activity, beta-adrenergic blockade and atrial natriuretic factor.
    Henriksen JH; Bendtsen F; Gerbes AL; Christensen NJ; Ring-Larsen H; Sørensen TI
    Hepatology; 1992 Nov; 16(5):1163-70. PubMed ID: 1358779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adrenomedullin increases cardiac sympathetic nerve activity in normal conscious sheep.
    Charles CJ; Jardine DL; Nicholls MG; Richards AM
    J Endocrinol; 2005 Nov; 187(2):275-81. PubMed ID: 16293775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.